baber/WOPTO huggingface dataset:
Patent CA-2613359-A1 (CA)
Title: Systeme et procede pour la protection haute performance de donnees d'entreprise
Inventor: LIU PETER CHI-HSIUNG
IPC: G06F21/24
Filed: 2006-06-23
Abstract: La présente invention a trait à un système et un procédé de protection haute performance de données au niveau de l'entreprise fournissant des instantanés efficaces incrémentaux au niveau des blocs de dispositifs de stockage principaux, et la disponibilité immédiate de tels instantanés sous une forme apte à être monté sur le champ qui peut être directement utilisée à la place du dispositif de stockage principal. L'invention a également trait à des systèmes et applications associés, comprenant une "Destination d'Images d'Entreprise" (EID) pour des images de sauvegarde; une technique d'écriture miroir grâce à laquelle une installation principale physique de substitution peut être créée tout en opérant une deuxième unité de stockage comme système de fichiers de source principal; et une technique pour l'élimination de données redondantes dans des images de sauvegarde lors de la sauvegarde d'une pluralité de systèmes avec des contenus partiellement communs (par exemple, des fichiers de système d'exploitation, des bases de données communes, des applications exécutables et autres). L'invention a trait en outre à une pluralité d'exemples illustrant la "Récupération d'Applications Rapide" (FAR) grâce à l'invention.
Patent CA-2613614-A1 (CA)
Inventor: ROY MITA
IPC: C07J9/00
Filed: 2006-06-21
Abstract: The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme Q10 or CoQ10 has the chemical name 2-r(all-trans)-3, 7, 11, 15, 19, 23, 27, 31, 35, 39 - decamethyl - 2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetracontadecaenyl] - 5, 6-dimethoxy -3- methyl -1,4-benzoquinone and has the formula (I). The invention also provides new intermediates useful for the preparation of CoQ10 and processes for their preparation.
Patent CA-2614097-A1 (CA)
Title: Polymer film for transdermal patches with pharmaceutical active
Inventor: BRACHT STEFAN
IPC: A61F13/02
Filed: 2006-07-17
Abstract: The invention relates to a polymer film for transdermal patches containing a pharmaceutical active agent. The polymer film comprises one or more layers having a content of at least one decomposition accelerator for pharmaceutical active agents. The inventive polymer film is, in the inventive combination with transdermal patches, which can contain pharmaceutical active agents from the group of gestagens, estrogens or androgens, can be used for the environmentally friendly disposal of these patches, for example, patches for hormone replacement therapy and for fertility control.
Patent CA-2616913-A1 (CA)
Inventor: ZUGMAIER GERHARD
IPC: C12Q1/68
Filed: 2006-05-24
Abstract: The invention is related to a method of predicting the response to a treatment with a HER dimerization inhibitor in a patient comprising the steps of assessing a marker gene or a combination of marker genes selected from the group consisting of an epidermal growth factor, a transforming growth factor alpha and a HER2 marker gene or a combination of marker genes comprising an amphiregulin marker gene and a marker gene selected from an epidermal growth factor, a transforming growth factor alpha and a HER2 marker gene in a biological sample from the patient and predicting the response to the treatment with the HER dimerization inhibitor in the patient by evaluating the results of the first step. Further uses and methods wherein these markers are used are disclosed.
Patent CA-2620468-A1 (CA)
Title: Microorganisms with increased efficiency for methionine synthesis
Inventor: KROEMER JENS
IPC: C12N15/52
Filed: 2006-08-18
Abstract: The present invention concerns methods for the production of microorganisms with increased efficiency for methionine synthesis. The present invention also concerns microorganisms with increased efficiency for methionine synthesis.  Furthermore, the present invention concerns methods for determining the optimal metabolic flux for organisms with respect to methionine synthesis.
Patent CA-2622067-A1 (CA)
Inventor: TURNER WILLIAM
IPC: G01D5/12
Filed: 2008-02-21
Abstract: The angular displacement of an inclined cam about the compressor slide valve shaft rotates an annular surface having a helically inclined face aligned with and spaced apart from a sensor head of a magnetic sensor mounted to the compressor. The rotation provides a linear variation in the size of the gap between the sensor head and the inclined ramp which directly corresponds to the compressor slide valve position between its fully closed and fully open positions. Linear variation in the size of the gap produces a correspondingly linear output signal from the magnetic sensor which provides the input for an analog input card in an associated programmable logic controller to determine the slide value position.
Patent CA-2624457-A1 (CA)
Inventor: CHARTIER DAVID
IPC: B64D27/18
Filed: 2006-09-29
Abstract: The invention concerns a turbojet engine mounting structure for aircraft comprising a central structure box (22) formed by the assembly of two panels joined via transverse ribs (23), the mounting structure further comprising two lateral structure boxes (24a) secured to a front part of the structure box (22) and arranged on either side thereof, each lateral structure box being provided with a rear closure frame (46a). The invention is characterized in that one of the ribs (23) forming the structure box (22) is equipped with two lateral extensions (52a) formed integrally with said rib (23) and respectively projecting from the two side panels outwards of the structure box (22), the two extensions (52a) being fixedly mounted on the frame (46a) of both the lateral structure boxes respectively.
Patent CA-2627125-A1 (CA)
Title: Compound operation input device
Inventor: TSUDUKI SHIRO
IPC: H01H25/00
Filed: 2008-03-27
Abstract: A compound operation input device includes: an first operating body that can be pressed in a direction substantially orthogonal to a circuit board; an second operating body of annular shape, disposed around the first operating body and substantially parallel to the circuit board, tilt operable, and rotatably operable; a first switch actuable in response to pressing movement of the first operating body; second switches independently actuable in response to tilt movement of the second operating body; an attachment having an outer portion, the second operating body being provided with the outer portion, and an inner portion facing the second face of the first operating body; and a rotation detector for detecting rotation of the second operating body. The rotation detector is attached to an inner portion of the attachment and disposed in a space between the circuit board and the first operating body and inside the second switches.
Patent CA-2630600-A1 (CA)
Inventor: ROBOTHAM JAMES L
IPC: A61K51/00
Filed: 2006-11-20
Abstract: The present invention is a mitochondria-targeted antioxidant prodrug useful for the prevention or treatment of diseases or conditions associated with mitochondrial dysfunction resulting from changes in the mitochondrial redox environment. Antioxidant prodrugs of the invention are produced by modifying an antioxidant to a fatty acid so that the resulting prodrug is targeted to and activated by an enzyme of mitochondrial fatty acid beta-oxidation.
Patent CA-2630920-A1 (CA)
Title: Inhibition of cell proliferation
Inventor: CHELLAPPAN SRIKUMAR
IPC: A61K39/395
Filed: 2006-11-22
Abstract: The disclosed modulators of Rb:Raf-1 interactions are potent, selective disruptors of Rb:Raf-1 binding, with IC50 values ranging from 80 nM to 500 nM.  Further, these compounds are surprisingly effective in inhibiting a wide variety of cancer cells, including osteosarcoma, epithelial lung carcinoma, non small cell lung carcinoma, three different pancreatic cancer cell lines, two different glioblastoma cell lines, metastatic breast cancer, melanoma, and prostate cancer. Moreover, the disclosed compounds effectively disrupt angiogenesis and significantly inhibited tumors in nude mice derived from human epithelial lung carcinoma tumors. Accordingly, the disclosed compounds, pharmaceutical compositions comprising the compounds, methods of inhibiting cell proliferation, methods of treating subjects with cancer, and methods of preparing the disclosed compounds are provided.
Patent CA-2631481-A1 (CA)
Inventor: ARMSTRONG BRIAN STEWART RANDAL
IPC: G06Q10/00
Filed: 2008-05-16
Abstract: A system for monitoring an unsupervised worker is provided that includes a plurality of sensors and a base station provided at the monitored location, a service provider server located remotely from the monitored location and operated by a third party service provider, and a computing device associated with a subscriber to the system. At least a portion of the sensed data is sent to and stored by the service provider server so that a report based thereon may, at the request of the system subscriber, be selectively generated and provided to the system subscriber. The computing device is also adapted to generate configuration data for one or more of the sensors and transmit the configuration data to the service provider server. The configuration data is then sent to the base station and used to control the operation of the sensors
Patent CA-2631897-A1 (CA)
Title: Sprayable dry wash and wax composition and method of using same
Inventor: SEROBIAN ASHOT
IPC: C11D3/37
Filed: 2008-05-21
Abstract: A composition for simultaneously cleaning and waxing non-porous surfaces without the need for additional rinsing of the treated surface with water, has a pH of from about 6 to about 7 and contains by weight: (a) from about 0.04 to about 0.12 % of an acrylic-based polymer, wherein the acrylic-based polymer is a hydrophobically modified, crosslinked polyacrylate powder which has been crosslinked with a polyalkenyl polyether or is an acrylic polymer containing acid groups and which dissolves and swells immediately when neutralized with an alkali salt (b) from about 0.5 to about 5.0% of a silicone blend composed of: (i) from about 70 to about 95% of a first polydiorganosiloxane fluid having a viscosity of from about 0.65 to about 60,000 centistokes at 25 C., and (ii) from about 5 to about 30% of a polydiorganosiloxane fluid mixture having a viscosity of from about 500 to about 2000 centistokes at 25 C., the polydiorganosiloxane fluid mixture being composed of a second polydiorganosiloxane fluid and a silicone resin; (c) wax; and (d) water. The composition can be used to simultaneously clean and wax non-porous surfaces such as the exterior surfaces of automobiles and other vehicles, windows, and the like.
Patent CA-2632009-A1 (CA)
Inventor: KANNAR DAVID
IPC: A61Q11/00
Filed: 2006-12-15
Abstract: A nitrogen complex of an inorganic phosphate comprising the anionic sub-structure (I); whereby a nitrogen atom (N) of a complexing agent is complexed to an oxygen atom (O) of the inorganic phosphate; wherein the nitrogen atom is selected from the group consisting of a nitrogen atom of an amine group or a nitrogen atom of a N-heteroaromatic ring; and wherein A and A' are each independently selected from the group of constituents consisting of a hydroxyl group (-OH), an oxide group (-O-) ,the group -OR where R is alkyl or substituted alkyl; an oxygen to which a nitrogen is complexed (-0.rarw.N) wherein the nitrogen atom is selected from the group consisting of a nitrogen atom of an amine group or a nitrogen atom of a N-heteroaromatic ring; and a phosphate of the form (i); wherein each of A" and A'" are selected independently from the same group of substituents as A and A"; wherein at least one of A, A', A" and A'" is an oxide (-O-) with the proviso that when A"  and A'" are not present then at least one of A and A' is an oxide (-O-).
Patent CA-2632648-A1 (CA)
Title: Medical device wireless adapter
Inventor: BAKER STEVEN D
IPC: G16H40/67
Filed: 2006-12-14
Abstract: The invention relates generally to a medical device wireless adapter, and more particularly, to a module that adapts an existing legacy or newly designed medical device to a healthcare provider's wireless infrastructure.
Patent CA-2633763-A1 (CA)
Inventor: PETER MANUELA
IPC: H05B33/12
Filed: 2006-11-02
Abstract: The present invention is an electroluminescent display that incorporates a laminated seal that inhibits exposure of display components to atmospheric contaminants and to a sealing process for fabrication of the same. The sealed electroluminescent display comprises a substrate upon which is constructed a thick dielectric electroluminescent display covered by a laminated seal comprising a lower multi-functional polymer film and an upper inorganic film that provides a barrier layer to inhibit exposure of the electroluminescent display structure to an atmospheric contaminant.
Patent CA-2634116-A1 (CA)
Inventor: KAMOGAWA YUMIKO
IPC: A61P37/02
Filed: 2006-12-20
Abstract: The present disclosure relates to novel monoclonal antibodies and fragments thereof which bind to an extracellular domain of human ILT7. The antibodies comprise amino acid sequences according to any one of the following (i) to (iii) as CDR1, CDR2 and CDR3 in the following heavy chain and light chain variable regions: i) CDR1 of a heavy chain variable region:  SDYAWN (SEQ ID NO: 58); CDR2 of a heavy chain variable region:  YISYSGSTSYNPSLKSR (SEQ ID NO: 59); and CDR3 of a heavy chain variable region: SPPYYAMDY (SEQ ID NO: 60); CDR1 of light chain variable region: KASQDVGTAVA (SEQ ID NO: 61); CDR2 of a light chain variable region: WASTRHT (SEQ ID NO: 62); and CDR3 of a light chain variable region:  QQYSSYPLT (SEQ ID NO: 63); ii) CDR1 of a heavy chain variable region:  SYWIH (SEQ ID NO: 64); CDR2 of a heavy chain variable region:  RIYPGTGSTYYNEKFKG (SEQ ID NO: 65); and CDR3 of a heavy chain variable region: YPTYDWYFDV (SEQ ID NO: 66); CDR1 of a light chain variable region: RASQSISNYLH (SEQ ID NO: 67); CDR2 of a light chain variable region: YASQSIS (SEQ ID NO: 68); and CDR3 of a light chain variable region: QQSNSWPLT (SEQ ID NO: 69); iii) CDRI of a heavy chain variable region: SDYAWN (SEQ ID NO: 70); CDR2 of a heavy chain variable region:  YISYSGSTSYNPSLKSR (SEQ ID NO: 71); and CDR3 of a heavy chain variable region: ALPLPWFAY (SEQ ID NO: 72); CDR1 of a light chain variable region: KASQDVGTAVA (SEQ ID NO: 73); CDR2 of a light chain variable region: WASTRHT (SEQ ID NO: 74); and CDR3 of a light chain variable region:  QQYSSYPYT (SEQ ID NO: 75). The disclosure also relates to polynucleotides encoding the antibody or fragment thereof and methods for producing the antibody. The novel antibodies and fragments thereof can be used to detect ILT7 expressing cells and to inhibit the secretion of interferon from ILT7 expressing cells.
Patent CA-2635692-A1 (CA)
Inventor: ORLOVSKY YEVGENIYA I
IPC: A61K39/395
Filed: 2006-12-28
Abstract: A human anti-IL-23pl9 antibody, including isolated nucleic acids that encode at least one anti-IL-23pl9 antibody, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Patent CA-2637721-A1 (CA)
Title: A method for manipulating screen assemblies and a screen assembly for a vibratory separator
Inventor: SCHULTE DAVID LEE JR
IPC: B07B1/46
Filed: 2004-02-04
Abstract: A method for manipulating screen assemblies in a vibratory separator, the method comprising the steps of positioning a first screen assembly in holding apparatus of a vibratory separator, connecting a second screen assembly to the first screen assembly and moving the first screen assembly by manipulating the second screen assembly. Also disclosed is a screen assembly for a vibratory separator, the screen assembly comprising screening material, a support for supporting the screening material and interconnection apparatus on the support for releasably connecting the screen assembly to an adjacent screen assembly.
Patent CA-2638515-A1 (CA)
Inventor: BEDFORD ANTHONY JONATHAN
IPC: A61M5/32
Filed: 2008-08-06
Abstract: A medical safety device is provided and includes a needle hub having a needle supported thereon; and a safety shield operatively mounted on the needle hub. The safety shield includes a pair of spaced legs and a foot member. Each proximal segment includes a camming surface. The safety shield further includes a trigger supported on the foot member. The trigger includes a camming member and is movable to move the camming member into engagement with the camming surfaces of the proximal segments to effect movement of the legs from a first position in which the distal ends of the distal segments shield a distal end of the needle to a second position in which the distal end of the needle is at least partially exposed. The trigger is removably secured to the foot member.
Patent CA-2640347-A1 (CA)
Title: Methods for simulating custom hair color results and thereby selecting and formulating custom hair coloring compositions
Inventor: GLATTFELDER MARTINA
IPC: G06F17/50
Filed: 2007-02-12
Abstract: Methods are disclosed for simulating custom hair color results, for selecting a resulting custom hair color from among possible custom hair color results, and for formulating custom hair coloring compositions which impart to hair such custom hair color results.
Patent CA-2640916-A1 (CA)
Title: Authentication method, corresponding portable object and computer software program
Inventor: NACCACHE DAVID
IPC: G06K19/073
Filed: 2008-10-10
Abstract: A method of authenticating a carrier of a portable object comprising means of memorising at least one item of secret information, comprising the following steps:  authentication processing of a signature provided by the carrier, taking account of the secret information;  supply of an item of information for the authentication decision, positive or negative; implementing, in a non volatile memory of the portable object, an incorrect signature indicator that may adopt a value indicating a normal situation and at least one value indicating an abnormal situation, and comprising: after the information supply step, a step for writing, in the incorrect signature indicator, a value indicating an abnormal situation, if the authentication decision is negative; and, before the authentication step, if the incorrect signature indicator contains a value indicating an abnormal situation, a step generating a delay. The writing step also comprises an operation for memorising at least one item of context-related information, such as the date and time and/or an identifier of the terminal used.
Patent CA-2642570-A1 (CA)
Inventor: FOUSER LYNETTE A
IPC: A61K39/395
Filed: 2007-02-21
Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22) and methods of using those antibodies, for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.
Patent CA-2643217-A1 (CA)
Inventor: SEGGER MARK
IPC: B32B9/00
Filed: 2007-03-14
Abstract: A structural insulated panel (10) for use in a mine safe room, which includes a carbon foam core (12) having a high ratio of compressive strength to density, desirable fire retardant properties, and resistance to environmental stress. The carbon foam structural insulated panel also includes a first layer (14) and a second layer (16) bound to a first surface and second surface of the carbon foam core.
Patent CA-2643661-A1 (CA)
Inventor: CASSADAY TERRY
IPC: B29C44/18
Filed: 2008-11-12
Abstract: The present invention relates to an apparatus for a ventilated chair backing assembly comprising: a foam chair backing component with a first plurality of ventilation holes extending from a front surface to a back surface, said plurality of holes having a skin; an internal support component with a second plurality of ventilation holes extending from a front surface to a back surface aligned to the first plurality of holes.
Patent CA-2646825-A1 (CA)
Title: Adjustable length patent foramen ovale (pfo) occluder and catch system
Inventor: AHERN JOHN
IPC: A61B17/00
Filed: 2007-03-29
Abstract: Devices, delivery systems and techniques for an occlusion device for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale (PFO), and other septal and vascular defects are described. The devices, delivery systems and techniques relate to, but are not limited to, a patent foramen ovale (PFO) occluder made from a substantially cylindrical form. An occluder having a distal side and a proximal side, with a catch system for securing the deployed configuration, is introduced into the treatment site by a delivery sheath. In one aspect, the occluder has an adjustable length center joint that allows the device to fit a particular septal defect. In some embodiments, the occluder includes a catch member that holds the occluder in the deployed, expanded profile configuration. In one aspect, the catch member also has an adjustable length.
Patent CA-2646915-A1 (CA)
Inventor: BENEY PIERRE-JEAN
IPC: A63F13/00
Filed: 2007-02-02
Abstract: A universal method and system for downloading game software to ROM based legacy gaming machines, activating selected games and providing new services. The method includes a ROM emulator for replacing the game program image and an NVRAM emulator for swapping the game context and critical meters accordingly. The method includes detection of the state of the current game activity such as to activate a new game only at an authorized time, when no player is playing a game or is carded-in for example. The system includes emulation of the original peripherals fitted to the legacy gaming machine such as to offer extended functionality and services. The universal method and system therefore prolongs the useful life of legacy machines which otherwise would be prematurely retired.
Patent CA-2647827-A1 (CA)
Inventor: ZOU RUIMING N
IPC: C07D405/00
Filed: 2007-04-02
Abstract: The present disclosure provides reagents that can be used to label synthetic oligonucleotides with rhodamine dyes or dye networks that contain rhodamine dyes.
Patent CA-2648623-A1 (CA)
Inventor: ECKLES ROBERT D
IPC: G01N21/00
Filed: 2007-03-07
Abstract: A multi-pass optical cell with an actuator for actuating a reflective surface is provided. In one preferred embodiment, an apparatus is provided comprising a first reflective surface, a second reflective surface, and a support structure supporting the first and second reflective surfaces. The support structure positions the first and second reflective surfaces to create an optical cell. The apparatus also comprises a source and a detector, which are positioned such that light emitted from the source is reflected in the optical cell at least one time between the first and second reflective surfaces before reaching the detector. The apparatus further comprises an actuator coupled with and operative to actuate the first reflective surface. In some embodiments, the actuator rotates the first reflective surface. Also, in some embodiments, the multi-pass optical cell is an open path multi-pass optical cell, while, in other embodiments, the multi-pass optical cell is a closed path multi-pass optical cell.
Patent CA-2651223-A1 (CA)
Inventor: SCHNEIDER BRETT M
IPC: A61N2/00
Filed: 2007-04-27
Abstract: The present invention provides for Stereotactic Transcranial Magnetic Stimulation (sTMS) at predetermined locations with the brain or spinal cord and incorporates an array of electromagnets arranged in a specified configuration where selected coils in the array are pulsed simultaneously. Activation of foci demonstrated by functional MRI or other imaging techniques can be used to locate the neural region affected. Imaging techniques can also be utilized to determine the location of the designated targets.